Cat. No. | Product Name / Activity |
---|---|
5318 | AEE 788 |
Potent EGFR and VEGFR inhibitor | |
6812 | Afatinib dimaleate |
Potent dual specificity EGFR/HER2 inhibitor; active in vivo | |
1276 | AG 1478 hydrochloride |
Highly potent EGFR-kinase inhibitor | |
0414 | AG 490 |
EGFR-kinase inhibitor. Also JAK2, JAK3 inhibitor | |
1555 | AG 825 |
Selective ErbB2 inhibitor | |
5916 | Canertinib dihydrochloride |
Potent EGFR kinase inhibitor | |
6231 | Dacomitinib |
Potent irreversible pan ErbB inhibitor | |
7424 | EMI 48 |
Inhibitor of EGFR mutants | |
7194 | Erlotinib Hydrochloride |
Potent, reversible EGFR tyrosine kinase inhibitor | |
1110 | Genistein |
EGFR kinase inhibitor. Also estrogen and PPARγ ligand | |
2239 | GW 583340 dihydrochloride |
Potent dual EGFR/ErbB2 inhibitor; orally active | |
6813 | Ibrutinib |
Potent ErbB4 inhibitor; also inhibits BTK | |
3000 | Iressa |
Orally active, selective EGFR inhibitor | |
6962 | JBJ-03-142-02 |
Highly potent EGFR and ErbB2 inhibitor; inhibts wild type and mutated receptors | |
3352 | JNJ 28871063 hydrochloride |
Potent ErbB receptor family inhibitor | |
6811 | Lapatinib |
Potent and selective dual ErbB2 (HER-2) and EGFR inhibitor | |
7371 | Neratinib |
Potent HER2 receptor tyrosine kinase and EGFR kinase inhibitor | |
2615 | PD 158780 |
Potent ErbB receptor family inhibitor | |
6349 | Pelitinib |
Potent and irreversible EGFR inhibitor; orally bioavailable | |
4941 | PKI 166 hydrochloride |
Potent EGFR-kinase inhibitor | |
2794 | PP 3 |
EGFR-kinase inhibitor. Also Src kinase negative control | |
3599 | TAK 165 |
Potent and selective ErbB2 inhibitor | |
7640 | Tucatinib |
Potent and selective ErbB2 inhibitor | |
3115 | WHI-P 154 |
Potent EGFR inhibitor. Also inhibits JAK3 | |
6290 | WZ 4002 |
Potent mutant-selective EGFR inhibitor |